Metastatic Castration-Resistant Prostate Cancer: Predictive Model for Overall Survival
Physician's Weekly,
Prognostic models for patients with metastatic castration-resistant prostate cancer (mCRPC) that are generalizable, current…
A novel prognostic model predicting overall survival in patients with metastatic castration‐resistant prostate cancer receiving standard chemotherapy: A multi‐trial cohort analysis
Overview of attention for article published in The Prostate, July 2022
Altmetric Badge
About this Attention Score
-
Good Attention Score compared to outputs of the same age (73rd percentile)
Readers on
- mendeley
- 4 Mendeley